{
    "Trade/Device Name(s)": [
        "Roche/Hitachi Urinary/CSF Protein"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K072638",
    "Predicate Device Reference 510(k) Number(s)": [
        "K913615"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JGQ"
    ],
    "Summary Letter Date": "September 17, 2007",
    "Summary Letter Received Date": "September 18, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1635"
    ],
    "Regulation Name(s)": [
        "Total Protein test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Protein"
    ],
    "Specimen Type(s)": [
        "Urine",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche automated clinical chemistry analyzers",
        "Hitachi analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetric endpoint assay",
        "Rate (kinetic) assay"
    ],
    "Methodologies": [
        "Quantitative determination",
        "Turbidimetric analysis"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Roche/Hitachi Urinary/CSF Protein reagent modification adding a rate assay for quantitative determination of protein in urine and CSF on Roche/Hitachi analyzers",
    "Indications for Use Summary": "In vitro test for quantitative determination of protein in urine and cerebrospinal fluid on Roche automated analyzers for diagnosis and treatment of renal, heart, thyroid, meningitis, brain tumors, and CNS disorders",
    "fda_folder": "Clinical Chemistry"
}